Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein versus celecoxib in symptomatic knee osteoarthritis
2015-002933-23Phase 4Completed
- Sponsor
- TRB Chemedica
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing Diacerein with Celecoxib (2 arms). Primary endpoint: Change in WOMAC A pain subscale. Started Mar 2016; status: completed.
02
Drugs
diacereincelecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2015-002933-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002933-23.